CD40LG and Thrombocytopenia: Administration of anti-CD40L prior to anti-MHC I injection significantly limited the severity of the thrombocytopenia (p < 0.05), although platelet levels remained significantly lower compared with untreated controls (p < 0.001) (Fig. 2A).